mafosfamide has been researched along with Cancer, Embryonal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blaney, SM; Boyett, J; Friedman, H; Gajjar, A; Geyer, R; Heideman, R; Horowtiz, M; Hunt, D; Kieran, M; Kun, L; Packer, R; Phillips, P; Pollack, IF; Prados, M | 1 |
1 trial(s) available for mafosfamide and Cancer, Embryonal
Article | Year |
---|---|
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Topics: Affect; Age Factors; Analgesics, Opioid; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cyclophosphamide; Dexamethasone; Female; Glucocorticoids; Headache; Humans; Infant; Injections, Spinal; Male; Maximum Tolerated Dose; Morphine; Neoplasms, Germ Cell and Embryonal; Pain | 2005 |